Is adult mortality or morbidity increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment : an analysis of the Hypopituitary Control and Complications Study ( HypoCCS )?
The results indicate no increased risk of mortality or incidence of cancer, stroke, or MI in adult GH-deficient patients who had previously received pediatric GH treatment.
Obese patients with recurrence after failed anti-reflux operation may be safely treated with a repeat operation. Our data indicate no difference in outcomes for patients with BMI>30, underscoring the importance of preoperative discussion as to the best approach: reoperative fundoplication or a gastric bypass.